Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
A quick beginner guide to selecting a SP 500 index fund for an IRA in 2024, covering costs, diversification, and what to look for in a starter fund.
23,805 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Copperlane unveils Penny, an autonomous AI loan officer, after a $4.1 million seed round, aiming to cut origination b...
Colgate-Palmolive topped earnings expectations and posted stronger cash flow, positioning it as a top defensive pick ...
Banking, housing finance groups urge federal regulators to tailor Basel III capital rules, arguing that overlap and h...
When a deal comes with no interior walkthrough, the smartest investors lean on data, systems, and creative financing....
Industry leaders urge a shift from hype to honest storytelling to rebuild trust in reverse mortgages. This report out...
A new forecast puts Europe’s biggest economies on track for more than $600 billion in heat-driven losses by 2030, for...
Bitcoin fell below $59,000 in a broad risk-off selloff, amplifying losses from leveraged bets. Analysts warn volatili...
A nobel laureate economist warns that anxiety about AI displacing workers risks shaping real outcomes, not just headl...
Sellers on online marketplaces can be blindsided when a buyer’s payment looks real but is fake. Learn how these scams...
A looming NBCUniversal spin-off reshapes the media landscape as Netflix weighs a transformative deal. If talks advanc...
A cluster of monthly buy signals across BTC, ETH, XRP, and SOL has traders debating whether the bear cycle is ending....